key: cord-0843699-ftlq96uw
authors: Latrous, Meriem; Zhu, Rongbo; Mack, Douglas P.; Soller, Lianne; Chan, Edmond S.; Jeimy, Samira; Hanna, Mariam; Abrams, Elissa M.; Cameron, Scott B.; Cook, Victoria E.; Erdle, Stephanie; Protudjer, Jennifer L.P.; Wong, Tiffany
title: Web-based Infant Food Introduction (WIFI): Feasibility and satisfaction of virtual allergist-supervised food introduction
date: 2021-05-26
journal: J Allergy Clin Immunol Pract
DOI: 10.1016/j.jaip.2021.05.012
sha: c8ca169b2b31621473e59f3898204e44864b6f39
doc_id: 843699
cord_uid: ftlq96uw

nan

The coronavirus disease 2019 (COVID-19) pandemic has limited access to in-person allergist assessments. Virtually supported food introduction can be a feasible and safe approach to avoid delays in high-risk individuals, supported by positive experience and high satisfaction rates for both caregivers and allergists.

The coronavirus disease 2019 (COVID-19) pandemic has resulted in the modification and postponement of many allergy clinic services. 1, 2 As a result, effective implementation of food allergy prevention poses a challenge, particularly in high-risk infants and families requiring support from health care providers for early introduction of allergenic foods. 3 This may, in turn, increase the risk of developing a potentially preventable allergy with recent and emerging literature advocating for a more liberal food introduction in infants. [4] [5] [6] The feasibility of virtually supported home peanut introduction was recently demonstrated through a case series. 7 Families interacted with the clinician at the beginning of the encounter and throughout the procedure, which was not burdensome to the physician and was appreciated by caregivers. However, the virtually supported encounters were limited to peanut introduction, and little is known regarding feasibility and satisfaction of allergists and caregivers during this process. Many countries are currently experiencing second and third waves of COVID-19, and virtually supported care is becoming increasingly important because in-person allergy services continue to be delayed. We performed a Canada-wide multicenter quality improvement initiative to further assess the safety and feasibility of virtually supported introduction of any allergenic food in high-risk infants. In addition, we explored both allergist and caregiver satisfaction of the virtually supported food introduction.

Infants (24 months) meeting our definition of high risk for development of food allergy ( Figure E1 , available in this article's Online Repository at www.jaci-inpractice.org) underwent virtually supported oral introduction to allergenic foods. Visits were held via secure telehealth platforms. An initial assessment of the child's health was performed prior to the virtually supported food introduction. Caregivers were counselled about the low risk of anaphylaxis at first ingestion, provided with food preparation instructions, and asked to obtain an epinephrine autoinjector (ideally 2) and nonsedating antihistamines ( Figure E1, B) . On the second visit, caregivers were instructed to feed their child increasing amounts of the chosen food every 10 to 15 minutes (as tolerated) over a period of 45 to 60 minutes. The target dose of allergenic food protein was 2 g or an age-appropriate serving size. 7 During this process, the allergist was available at all times to assist caregivers virtually in the event of a reaction. Surveys were given to caregivers before and after the virtual encounter to evaluate their satisfaction with virtually supported food introduction measured on a numerical scale from 1 to 100 as well as to assess potential reasons for food introduction hesitancy. Surveys were given to allergists following the encounter to document outcome of the procedure and to evaluate their satisfaction with virtually supported food introduction measured on a numerical scale from 1 to 100. The University of British Columbia/BC Children's Hospital Research Ethics Board waives quality improvement projects from formal Research Ethics Board application processes.

Between May 14 and October 31, 2020, 40 infants underwent virtually supported food introduction. 28 of 40 participants completed the baseline survey; the median age of the child was 9 months (interquartile range 7-11 months), and 12 infants (43%) had preexisting food allergies, 83% of which had been diagnosed by a pediatric allergist (Table I) . The most frequent reasons for food introduction hesitancy were fear of a potential allergic reaction (57%; n ¼ 16) and an existing food allergy in the child (39%; n ¼ 11). Caregivers were most hesitant to introduce tree nuts (46%; n ¼ 13), shellfish (46%; n ¼ 13), and peanuts (36%; n ¼ 10), with many caregivers concerned about introducing multiple foods.

Allergists completed postvisit surveys on 40 patients who underwent virtually supported allergenic food introductions, of whom 32 (75%) had a history of eczema. The most common foods introduced through the virtual encounter were peanuts (50%; n ¼ 20) followed by tree nuts (40%; n ¼ 16). Thirtyfive patients (88%) passed the virtually supported food introduction, and 5 patients (13%) had a reaction during the virtually supported food introduction, with 1 patient requiring 1 dose of epinephrine. Of the 5 patients who reacted, 3 (60%) reacted to peanut. Four (80%) had a history of eczema, and 3 (60%) had completed skin prick testing before virtually supported food introduction. Out of the 20 virtually supported peanut introductions, 15 patients (75%) were less than 12 months of age and considered at high risk of developing peanut allergy based on the National Institute of Allergy and Infectious Diseases (NIAID) guidelines on early allergenic food introduction. 8 In this infant group, 8 (53%) had egg allergy, 11 (73%) had eczema, and 7 (47%) had both eczema and egg allergy. Only 1 infant in this group had a reaction during the virtually supported peanut introduction. This patient did not have prior skin prick testing and only had a mild reaction during virtually supported food introduction requiring no treatment (Table E1 ; available in this article's Online Repository at www.jaci-inpractice.org).

A total of 18 of 28 caregivers completed the postvisit survey. Compared with the baseline surveys, the postvisit surveys demonstrated that the caregivers had increased confidence in introducing allergenic foods, recognizing signs and symptoms of allergic reactions, and treating allergic reactions (Table II) . Following the virtual encounter, 12 caregivers (67%) planned to introduce new foods to their infant that they otherwise would not have, with tree nuts most likely to be introduced (67%; n ¼ 12). The median caregiver satisfaction of virtually supported food introduction was 99 of 100, with 15 caregivers (83%) opting into this method in the future if it meant shorter wait times. The median allergist satisfaction score of virtually supported food introduction was 99 of 100 on a satisfaction scale, and 98% (n ¼ 39) stated they would continue to offer virtually supported food introduction even when in-person visits become fully available.

Our quality improvement initiative demonstrated the safety and feasibility of virtual food introduction in high-risk infants, with caregivers and allergists reporting high levels of satisfaction. A small sample size is a limitation of this initiative, but we have provided proof of concept in the context of the current pandemic where improving access to care is important for high-risk infants in a critical window of time in which food introduction can help prevent the development of food allergies. 3,6-8 Virtual care allows flexibility from the perspective of patients and their families, minimizing travel and improving access to patients living in remote communities. Virtual care also allows procedures to be performed in a more comfortable, familiar, and relaxing environment for the patient and caregiver. In addition, virtual care can minimize the risk of acquiring COVID-19, reduce unnecessary patient backlog, and reduce long-term cost to the health care system. Virtually supported food introduction is an innovative and practical method 

COVID-19: pandemic contingency planning for the allergy and immunology clinic

Telemedicine in the era of COVID-19

Timing of introduction, sensitization, and allergy to highly allergenic foods at age 3 years in a general-population Canadian cohort

Food-induced anaphylaxis in infants: can new evidence assist with implementation of food allergy prevention and treatment?

Age and eczema severity, but not family history, are major risk factors for peanut allergy in infancy

A consensus approach to the primary prevention of food allergy through nutrition: guidance from the American Academy of Allergy

American College of Allergy, Asthma, and Immunology; and the Canadian Society for Allergy and Clinical Immunology

Virtually supported home peanut introduction during COVID-19 for at-risk infants

Addendum guidelines for the prevention of peanut allergy in the United States: report of the National Institute of Allergy and Infectious Diseasesesponsored expert panel